ArticleMolecules (Basel, Switzerland)2022

Miglitol, an Oral Antidiabetic Drug, Downregulates Melanogenesis in B16F10 Melanoma Cells through the PKA, MAPK, and GSK3β/β-Catenin Signaling Pathways.

Hyeon-Mi Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.